- Home
- LVLU vs INBS Comparison
LVLU vs INBS Comparison
Compare LVLU & INBS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- LVLU
- INBS
- Stock Information
- Founded
- LVLU 1996
- INBS 2016
- Country
- LVLU United States
- INBS United States
- Employees
- LVLU N/A
- INBS N/A
- Industry
- LVLU Catalog/Specialty Distribution
- INBS Medical Specialities
- Sector
- LVLU Consumer Discretionary
- INBS Health Care
- Exchange
- LVLU Nasdaq
- INBS Nasdaq
- Market Cap
- LVLU 11.3M
- INBS 11.7M
- IPO Year
- LVLU 2021
- INBS N/A
- Fundamental
- Price
- LVLU $4.58
- INBS $1.85
- Analyst Decision
- LVLU Hold
- INBS
- Analyst Count
- LVLU 1
- INBS 0
- Target Price
- LVLU $15.00
- INBS N/A
- AVG Volume (30 Days)
- LVLU 163.6K
- INBS 127.5K
- Earning Date
- LVLU 11-12-2025
- INBS 11-06-2025
- Dividend Yield
- LVLU N/A
- INBS N/A
- EPS Growth
- LVLU N/A
- INBS N/A
- EPS
- LVLU N/A
- INBS N/A
- Revenue
- LVLU $292,337,000.00
- INBS $3,052,532.00
- Revenue This Year
- LVLU N/A
- INBS $778.48
- Revenue Next Year
- LVLU $2.53
- INBS N/A
- P/E Ratio
- LVLU N/A
- INBS N/A
- Revenue Growth
- LVLU N/A
- INBS N/A
- 52 Week Low
- LVLU $2.98
- INBS $1.10
- 52 Week High
- LVLU $28.05
- INBS $2.75
- Technical
- Relative Strength Index (RSI)
- LVLU 55.24
- INBS 62.57
- Support Level
- LVLU $3.69
- INBS $1.68
- Resistance Level
- LVLU $6.40
- INBS $1.82
- Average True Range (ATR)
- LVLU 0.62
- INBS 0.12
- MACD
- LVLU 0.10
- INBS 0.03
- Stochastic Oscillator
- LVLU 35.16
- INBS 96.05
About LVLU Lulu's Fashion Lounge Holdings Inc.
Lulus Fashion Lounge Holdings Inc is a fashion brand serving Millennial and Gen Z women. Its products include Fall Dresses, Winter Dresses, Sweater Dresses, Short Dresses, Casual Dresses, Wedding Dresses, and Denims, among others. The company generates majority of its revenue from customers based in the United States.
About INBS Intelligent Bio Solutions Inc.
Intelligent Bio Solutions Inc is a life sciences company developing non-invasive, real-time monitoring and diagnostic tests for patients and their primary health practitioners. Its Biosensor Platform is developing and launching diagnostic tests urgently needed to help people living with chronic diseases. It also engages in the advancement of portable drug abuse testing through the analysis of fingerprint sweat. The test is non-invasive, hygienic, and fast, and screens for recent use of opioids, cocaine, methamphetamines, benzodiazepines, and marijuana. The company business through two operating segments include Commercially available Intelligent Fingerprinting Products (IFPG or IFPG segment) and, Development Stage Biosensor Platform Technology (BPT segment).